Gou Y - Search Results

1

LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway.

Wang J, Xiao Q, Chen X, Tong S, Sun J, Lv R, Wang S, Gou Y, Tan L, Xu J, Fan C, Ding G. Wang J, et al. Among authors: gou y. Cell Death Dis. 2018 Feb 7;9(2):197. doi: 10.1038/s41419-017-0207-0. Cell Death Dis. 2018. PMID: 29416001 Free PMC article.

2

Overexpression of WDFY2 inhibits prostate cancer cell growth and migration via inactivation of Akt pathway.

Wang J, Chen X, Tong S, Zhou H, Sun J, Gou Y, Wu F, Hu J, Xu J, Ding G. Wang J, et al. Among authors: gou y. Tumour Biol. 2017 Jun;39(6):1010428317704821. doi: 10.1177/1010428317704821. Tumour Biol. 2017. PMID: 28653900 Free article.

3

Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.

Hu Q, Tong S, Zhao X, Ding W, Gou Y, Xu K, Sun C, Xia G. Hu Q, et al. Among authors: gou y. Cell Physiol Biochem. 2015;36(2):799-809. doi: 10.1159/000430139. Epub 2015 May 22. Cell Physiol Biochem. 2015. PMID: 26021267 Free article.

4

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q. Chen Z, et al. Among authors: gou y. PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082147 Free PMC article.

5

Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?

Ding W, Chen Z, Gou Y, Sun C, Xu K, Tan J, Tong S, Xia G, Ding Q. Ding W, et al. Among authors: gou y. Cancer Epidemiol. 2014 Apr;38(2):157-61. doi: 10.1016/j.canep.2014.02.001. Epub 2014 Mar 11. Cancer Epidemiol. 2014. PMID: 24629527

6

Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Ding W, Tong S, Gou Y, Sun C, Wang H, Chen Z, Tan J, Xu K, Xia G, Ding Q. Ding W, et al. Among authors: gou y. World J Urol. 2015 Dec;33(12):1951-7. doi: 10.1007/s00345-015-1557-9. Epub 2015 Apr 18. World J Urol. 2015. PMID: 25894367

7

Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma.

Wu Y, Zhang N, Li K, Chen H, Lin X, Yu Y, Gou Y, Hou J, Jiang D, Na R, Wang X, Ding Q, Xu J. Wu Y, et al. Among authors: gou y. Oncotarget. 2016 Apr 5;7(14):18631-7. doi: 10.18632/oncotarget.7623. Oncotarget. 2016. PMID: 27229762 Free PMC article.

8

Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population.

Zhang N, Wu Y, Gong J, Li K, Lin X, Chen H, Yu Y, Gou Y, Hou J, Jiang D, Na R, Wang X, Ding Q, Xu J. Zhang N, et al. Among authors: gou y. Oncotarget. 2017 Apr 11;8(15):24196-24201. doi: 10.18632/oncotarget.6917. Oncotarget. 2017. PMID: 26918600 Free PMC article.

9

Periostin: a promising target of therapeutical intervention for prostate cancer.

Sun C, Zhao X, Xu K, Gong J, Liu W, Ding W, Gou Y, Xia G, Ding Q. Sun C, et al. Among authors: gou y. J Transl Med. 2011 Jun 30;9:99. doi: 10.1186/1479-5876-9-99. J Transl Med. 2011. PMID: 21714934 Free PMC article.

10

The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.

Hu Q, Gou Y, Sun C, Ding W, Xu K, Gu B, Xia G, Ding Q. Hu Q, et al. Among authors: gou y. Urol Oncol. 2014 Jan;32(1):50.e1-8. doi: 10.1016/j.urolonc.2013.07.016. Epub 2013 Nov 13. Urol Oncol. 2014. PMID: 24239465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

797 results

Search Page

Filters